Quick answer
Corcept Therapeutics Inc (CORT) reported revenue of $761.4M and net income of $99.7M for the fiscal year ended 2025-12-31, up 12.8% from $675.0M the year before, per its 10-K filed with the SEC on 2026-02-24.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $761.4M | $99.7M | — |
| 2024 (FY ending 2024-12-31) | $675.0M | $141.2M | — |
| 2023 (FY ending 2023-12-31) | $482.4M | $106.1M | — |
| 2022 (FY ending 2022-12-31) | $401.9M | $101.4M | — |
| 2021 (FY ending 2021-12-31) | $366.0M | $112.5M | — |
| 2020 (FY ending 2020-12-31) | $353.9M | $106.0M | — |
| 2019 (FY ending 2019-12-31) | $306.5M | $94.2M | — |
| 2018 (FY ending 2018-12-31) | $251.2M | $75.4M | — |
| 2017 (FY ending 2017-12-31) | $159.2M | $129.1M | $0.0M |
| 2016 (FY ending 2016-12-31) | $81.3M | $8.1M | $0.0M |
Related
- COO revenue, net income and debt history (The Cooper Companies, Inc.)
- COP revenue, net income and debt history (ConocoPhillips)
- COR revenue, net income and debt history (Cencora, Inc.)
- COST revenue, net income and debt history (Costco Wholesale Corp /New)
- CPAY revenue, net income and debt history (Corpay, Inc)
- CPNG revenue, net income and debt history (Coupang, Inc.)
- CPRT revenue, net income and debt history (Copart, Inc.)
- CPT revenue, net income and debt history (Camden Property Trust)
Last updated 2026-10-16. Data only, not financial or tax advice.